High susceptibility to the novel antimicrobial zoliflodacin among Neisseria gonorrhoeae isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024

We show a high susceptibility to zoliflodacin internationally, including against ceftriaxone- and azithromycin-resistant gonococcal strains. Our findings support the continued clinical development of zoliflodacin as a treatment for gonorrhea, although cautious and monitored introduction and continuous international resistance surveillance are imperative.

Authors

Institutions

Publication Details

Journal
IJID Regions
Published
2025-03-11
DOI
https://doi.org/10.1016/j.ijregi.2025.100624
Citations
3
Primary Topic
Reproductive tract infections research
Type
article
Field-Weighted Citation Impact
3.55
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High susceptibility to the novel antimicrobial zoliflodacin among Neisseria gonorrhoeae isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024

Teodora Wi, Manuel C Jamoralin, Vichea Ouk, Ismaël Maatouk et al.
3 citations
IJID Regions
Reproductive tract infections research
3.55
article

High susceptibility to the novel antimicrobial zoliflodacin among Neisseria gonorrhoeae isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024

Teodora Wi, Manuel C Jamoralin, Vichea Ouk, Ismaël Maatouk, Peter Kyambadde, Thuy Thi Phan Nguyen, E Müller, Daniel Golparian, Francis Kakooza, Sonia Sia, Phạm Thị Làn, Magnus Unemo, Nguyễn Thị Thuỳ Vân, Rossaphorn Kittiyaowamarn, Mitch Matoga, Thitima Cherdtrakulkiat, Vivi Setiawaty, Mot Virak, Heng Li, Irving Hoffman, Dumisile V. Maseko, Susanne Jacobsson, Daniel Schröder, Verawati Sulaiman
article en
3 citations

Abstract

We show a high susceptibility to zoliflodacin internationally, including against ceftriaxone- and azithromycin-resistant gonococcal strains. Our findings support the continued clinical development of zoliflodacin as a treatment for gonorrhea, although cautious and monitored introduction and continuous international resistance surveillance are imperative.

IJID RegionsVol. 15
National Health Laboratory Service (ZA), Department of Health (PH), Ministry of Public Health (TH), Örebro University (SE), Research Institute for Tropical Medicine (PH), Ministry of Health (UG), National Institute of Public Health (KH), World Health Organization (CH), National Center for HIV/AIDS, Dermatology and STD (KH), HCMC Hospital of Dermato Venereology (VN), Infectious Diseases Institute (UG), Hanoi Medical University Hospital (VN), University College London (GB), Makerere University (UG)
Partnerships for the goals
Openalex Percentile: Top 8%
Reproductive tract infections research
3.55
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.